RALGAPA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.645800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.765600E-01
Normal-vs-Stage2
1.451950E-01
Normal-vs-Stage3
2.114600E-01
Normal-vs-Stage4
4.695000E-01
Stage1-vs-Stage2
2.769000E-01
Stage1-vs-Stage3
3.456400E-02
Stage1-vs-Stage4
6.067600E-01
Stage2-vs-Stage3
2.350400E-04
Stage2-vs-Stage4
8.699600E-01
Stage3-vs-Stage4
1.348390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.043400E-01
Normal-vs-AfricanAmerican
4.534200E-01
Normal-vs-Asian
1.015040E-01
Caucasian-vs-AfricanAmerican
9.332000E-01
Caucasian-vs-Asian
2.415600E-01
AfricanAmerican-vs-Asian
3.578200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.022000E-01
Normal-vs-Female
4.387800E-01
Male-vs-Female
9.643600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.317400E-01
Normal-vs-Age(41-60Yrs)
6.336600E-01
Normal-vs-Age(61-80Yrs)
2.743200E-01
Normal-vs-Age(81-100Yrs)
7.829900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.053200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.312200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.298300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.529370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.029900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.510000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.490300E-02
Normal-vs-Daily Drinker
3.711200E-01
Normal-vs-Weekly Drinker
1.932750E-01
Normal-vs-Occasional Drinker
8.435200E-01
Normal-vs-Social Drinker
9.035000E-01
Non Drinker-vs-Daily Drinker
4.590400E-01
Non Drinker-vs-Weekly Drinker
9.856400E-01
Non Drinker-vs-Occasional Drinker
1.153010E-01
Non Drinker-vs-Social Drinker
1.769220E-01
Daily Drinker-vs-Weekly Drinker
5.837600E-01
Daily Drinker-vs-Occasional Drinker
3.051400E-01
Daily Drinker-vs-Social Drinker
3.621600E-01
Weekly Drinker-vs-Occasional Drinker
1.595370E-01
Weekly Drinker-vs-Social Drinker
2.087600E-01
Occasional Drinker-vs-Social Drinker
9.283800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.292790E-01
Normal-vs-Grade 2
3.396800E-03
Normal-vs-Grade 3
1.044110E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.334500E-02
Grade 1-vs-Grade 3
5.405500E-02
Grade 1-vs-Grade 4
1.292790E-01
Grade 2-vs-Grade 3
6.156000E-01
Grade 2-vs-Grade 4
3.396800E-03
Grade 3-vs-Grade 4
1.044110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.985600E-02
Normal-vs-NonDiabetic
4.514200E-01
Diabetic-vs-NonDiabetic
9.578000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.803400E-01
Normal-vs-NoPancreatitis
3.828600E-01
Pancreatitis-vs-NoPancreatitis
4.522800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.233800E-01
Normal-vs-N1
1.739200E-01
N0-vs-N1
3.831400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.919000E-01
Normal-vs-TP53-NonMutant
9.480600E-01
TP53-Mutant-vs-TP53-NonMutant
3.955200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
